SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001395064-21-000117
Filing Date
2021-06-21
Accepted
2021-06-21 06:05:05
Documents
18
Period of Report
2021-06-21

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k-2x062121.htm 6-K 11833
2 EX-99.1 executive_compensation.htm EX-99.1 38958
3 GRAPHIC executive_compensation001.jpg GRAPHIC 166278
4 GRAPHIC executive_compensation002.jpg GRAPHIC 177079
5 GRAPHIC executive_compensation003.jpg GRAPHIC 158721
6 GRAPHIC executive_compensation004.jpg GRAPHIC 191758
7 GRAPHIC executive_compensation005.jpg GRAPHIC 189997
8 GRAPHIC executive_compensation006.jpg GRAPHIC 148584
9 GRAPHIC executive_compensation007.jpg GRAPHIC 123187
10 GRAPHIC executive_compensation008.jpg GRAPHIC 178942
11 GRAPHIC executive_compensation009.jpg GRAPHIC 175133
12 GRAPHIC executive_compensation010.jpg GRAPHIC 162701
13 GRAPHIC executive_compensation011.jpg GRAPHIC 179293
14 GRAPHIC executive_compensation012.jpg GRAPHIC 175216
15 GRAPHIC executive_compensation013.jpg GRAPHIC 154037
16 GRAPHIC executive_compensation014.jpg GRAPHIC 140216
17 GRAPHIC executive_compensation015.jpg GRAPHIC 175481
18 GRAPHIC executive_compensation016.jpg GRAPHIC 65954
  Complete submission text file 0001395064-21-000117.txt   3582664
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 211027080
SIC: 2834 Pharmaceutical Preparations